Parkinson's disease, autoimmunity, and olfaction

International Journal of Neuroscience

Volumn 119, Issue 12, 2009, Pages 2133-2143

  Benkler, Michal ^a   Agmon Levin, Nancy ^a   Shoenfeld, Yehuda ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoantibodies; Autoimmune diseases; Dopaminergic system; Immune system; Olfactory system; Parkinson's disease

Indexed keywords

AUTOANTIBODY; GANGLIOSIDE GM1;

ADAPTIVE IMMUNITY; AUTOIMMUNITY; CEREBROSPINAL FLUID; HUMAN; HUMORAL IMMUNITY; MULTIPLE SCLEROSIS; NONHUMAN; OLFACTORY SYSTEM; PARKINSON DISEASE; PATHOGENESIS; REVIEW; SMELLING; SUBSTANTIA NIGRA; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; HUMANS; OLFACTION DISORDERS; PARKINSON DISEASE; SMELL;

EID: 70450213364     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207450903178786     Document Type: Review

References (51)

1. Abramsky, O., &Litvin, Y. (1978). Autoimmune response to dopamine-receptor as a possible mechanism in the pathogenesis of Parkinson's disease and schizophrenia. Perspectives in Biology and Medicine, 22, 104-114.
2. Al-Fulaij, M. A., Ren, Y., Beinborn, M., &Kopin, A. S. (2008). Pharmacological analysis of human D1 and D2 dopamine receptor missense variants. Journal of Molecular Neuroscience, 34, 211-223.
3. Boundy, V. A., Luedtke, R. R., Artymyshyn, R. P., Filtz, T. M., &Molinoff, P. B. (1993). Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides. Molecular Pharmacology, 43, 666-676.
4. Braak, H., &Del Tredici, K. (2009). Neuroanatomy and pathology of sporadic Parkinson's disease. Advances in Anatomy, Embryology and Cell Biology, 201, 1-119.
5. Buck, L., &Axel, R. (1991). A novel multigene family may encode odorant receptors: A molecular basis for odor recognition. Cell, 65, 175-187.
6. Carvey, P. M., McRae, A., Lint, T. F., Ptak, L. R., Lo, E. S., Goetz, C. G., et al. (1991). The potential use of dopamine neuron antibody and a striatal-derived neurotropic factor as diagnostic markers in Parkinson's disease. Neurology, 41, 53-58.
7. Chazot, P. L., Doherty, A. J., &Stange, P. G. (1993). Antisera specific for D2 dopamine receptors. Biochemical Journal, 289, 789-794.
8. Chen, S., Le, W. D., Xie, W. J., Alexianu, M. E., Engelhardt, J. I., Siklos, L., et al. (1998). Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins. Archives of Neurology, 55, 1075-1080.
9. Crossman, A. R. (2000). Functional anatomy of movement disorders. Journal of Anatomy, 196, 519-525.
10. Cztonkwska, A., Jastrzebska, I. K., Cztonkowski, A., Peter, D., &Stefano, G. B. (2002). Immune processes in the pathogenesis of Parkinson's disease-A potential role of microglia and nitric oxide. Medical Science Monitor, 8, 165-177.
11. Farooqui, S. M., &Prasad, C. (1992). An antibody to dopamine D2 receptor inhibits dopamine antagonist and agonist binding to dopamine D2 receptor cDNA transfected mouse fibroblast cells. Life Science, 51, 1509-1516.
12. Farooqui, S. M., Brock, J. W., Hamdi, A., &Prasad, C. (1991). Antibodies against synthetic peptides predicted from the nucleotide sequence ofD2 receptor recognize native dopamine receptor protein in rat striatum. Journal of Neurochemistry, 57, 1363-1369.
13. Fiszer, U., Mix, E., Fredrikson, S., Kostulas, V., Olsson, T., &Link, H. (1994). Gamma delta+ T cells are increased in patients with Parkinson's disease. Journal of the Neurological Sciences, 121, 39-45.
14. He, Y., Le, W. D., &Appel, S. H. (2002). Role of FC? receptors in nigral cell injury induced by Parkinson's disease immunoglobulin injection into mouse substantia nigra. Experimental Neurology, 176, 322-327.
15. Israel, Z., &Hassin-Bear, S. (2005). Subthalamic stimulation for Parkinson's disease. IMAJ, 7, 458-463.
16. Jellinger, K. A. (2008). A critical reappraisal of current staging of Lewy-related pathology in human brain. Acta Neuropathologica, 116, 1-16.
17. Johnston, J. M., Wood, D. F., James, J. D., &Johanston, D. G. (1992). Preparation and characterization of an antibody specific to the rat dopamine D2 receptor. Journal of Endocrinology, 134, 227-233.
18. Katzav, A., Ben-Ziv, T., Chapman, J., Blank, M., Reichlin, M., &Shoenfeld, Y. (2008). Anti-P ribosomal antibodies induce defect in smell capability in a model of CNSSLE (depression). Journal of Autoimmune, 21, 393-398.
19. Katzav, A., Solodeev, I., Brodsky, O., Chapman, J., Pick, C. J., Blank, M., et al. (2007). Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis &Rheumatism, 56, 938-948.
20. Kowalski, J., Blada, P., Kucia, K., Madej, A., &Herman, Z. S. (2001). Neuroleptics normalize increased release of interleukin-1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia. Schizophrenia Research, 50, 169-175.
21. Le, W. D., Rowe, D. B., Jankovic, J., Xei, W., &Apple, S. H. (1999). Effects of cerebrospinal fluid from patients with Parkinson disease on dopaminergic cells. Archives of Neurology, 56, 194-200.
22. Lerler, A., &Bagic, A. (2008). Olfactory pathogenesis of idiopathic Parkinson disease revisited. Movement Disorders, 23, 1076-1084.
23. Lesage, S., &Brice, A. (2009). Parkinson's disease: From monogenic forms to genetic susceptibility factors. Human Molecular Genetics, 18, 48-59.
24. Liu, B., Gao, H. M., &Hong, J. S. (2003). Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injury: Role of neuroinflammation. Environmental Health Perspectives, 111, 1065-1073.
25. Luedtke, R. R., Griffin, S. A., Conroy, S. S., Jin, X., Pinto, A., &Sesack, S. R. (1999). Immunoblot and immunohistochemical comparison of murine monoclonal antibodies specific for the rat D1a and D1b dopamine receptor subtypes. Journal of Neuroimmunology, 101, 170-187.
26. Marras, C., &Lang, A. (2008). Invited article: Changing concepts in Parkinson disease. Neurology, 70, 1996-2003.
27. Møller, A., Perrild, H., Pedersen, H., &Høier-Madsen, M. (1989). Parkinson's disease and autoimmunity. Acta Neurologica Scandinavica, 79, 173-175.
28. Mombaerts, P. (2004). Love at first smell-The 2004 nobel prize in physiology or medicine. New England Journal of Medicine, 351, 2579-2580.
29. Moscavitch, S. D., Szyper-Kravitz,M., Shoenfeld, Y. (2009). Autoimmune pathology accounts for common manifestations in a wide range of neuro-psychiatric disorders: The olfactory and immune system interrelationship. Clinical Immunology, 130, 235-243.
30. Myers, P. R., Donlon, M., McCarthy, K., Livengood, D., &Shain, W. (1976). Evidence for a dopamine receptor antibody. Biochemical and Biophysical Research Communications, 72, 1311-1318.
31. Neef, D. (2006). Walling AD. Dementia with Lewy bodies: An emerging disease. American Family Physician, 73, 1223-1229.
32. Nussbaum, R. L., &Ellis, C. E. (2003). Alzheimer's disease and Parkinson disease. New England Journal of Medicine, 348, 1356-1364.
33. Orr, C. F., Rowe, D. B., Mizuno, Y., Mori, H., &Halliday, G. M. (2005). A possible role of humoral immunity in the pathogenesis of Parkinson's disease. Brain, 128, 2665-2674.
34. Papachroni, K. K., Ninkina, N., Papapanagiotou, A., Hadjigeorgiou, G. M., Xiromerisiou, G., Papadimitriou, A., et al. (2007). Autoantibodies to alpha-synuclein in inherited Parkinson's disease. Journal of Neurochemistry, 101, 749-756.
35. Plug, M. J., Maassen, J. A., &Moller, W. (1992). An anti-peptide antibody that recognizes the dopamine D2 receptor from bovine striatum. European Journal of Biochemistry, 206, 123-130.
36. Rolls, E. T. (2005). Taste, olfactory, and food texture processing in the brain, and the control of food intake. Physiology &Behavior, 85, 45-56.
37. Rosner, S., Giladi, N., &Orr-Urtreger, A. (2008). Advances in the genetics of Parkinson's disease. Acta Pharmacologica Sinica, 29, 21-34.
38. Shoenfeld, N., Agmon-Levin, N., Flitman-Katzevman, I., Paran, D., Katz, B.S., Kivity, S., Langevitz, P., Zandman-Goddard, G., Shoenfeld, Y. (2009). The sense of smell in systemic lupus erythematosus. Arthritis Rheum., 60, 1484-1487.
39. Shoenfeld, Y. (2007). To smell autoimmunity: Anti-P-ribosomal autoantibodies, depression, and the olfactory system. Journal of Autoimmune, 28, 165-169.
40. Shoenfeld, Y., Blank, M., Abu-Shakra, M., Amital, H., Barzilai, O., Berkun, Y., et al. (2008). The mosaic of autoimmunity: Prediction, autoantibodies and therapy in autoimmune disease. IMAJ, 10, 13-19.
41. Shoenfeld, Y., Gilburd, B., Abu-Shakra, M., Amital, H., Barzilai, O., Berkun, Y., et al. (2008). The mosaic of autoimmunity: Genetic factor involved in autoimmune disease. IMAJ, 10, 3-7.
42. Shoenfeld, Y., Zandman-Goddard, G., Stojanovich, L., Cutolo, M., Amital, H., Levy, Y., et al. (2008). The mosaic of autoimmunity: Hormonal and environmental factors involved in autoimmune disease. IMAJ, 10, 8-12. (Pubitemid 351649455)
43. Strous, R. D., &Shoenfeld, Y. (2006a). Schizophrenia, autoimmunity and immune system dysregulation: A comprehensive modal updated and revised. Journal of Autoimmune, 27, 71-80.
44. Strous, R. D., &Shoenfeld, Y. (2006b). To smell the immune system: Olfaction, autoimmunity and brain involvement. Autoimmunity Reviews, 6, 54-60.
45. Toubi, E., &Shoenfeld, Y. (2007). Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmunity Reviews, 6, 119-125.
46. Uitti, R. J., &Calne, D. B. (1993). Pathogenesis of idiopathic parkinsonism. European Neurology, 33, 6-23.
47. Valldeoriola, F. (1999). Movement disorders of autoimmune origin. Journal of Neurology, 246, 423-431.
48. Wilson, R. S., Arnold, S. E., Buchman, A. S., Tang, Y., &Bennett, D. A. (2008). Odor identification and progression of parkinsonian signs in older persons. Experimental Aging Research, 34, 173-187.
49. Zandman-Goddard, G., Chapman, J., &Shoenfeld, Y. (2007). Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin Arthritis Rheum, 36, 297-315.
50. Zappia, M., Crescibene, L., Bosco, D., Arabia, G., Nicoletti, G., Bagala, A., et al. (2002).Anti-GM1 ganglioside antibodies in Parkinson's disease. Acta Neurologica Scandinavica, 106, 54-57.
51. Zorzon, M., Ukmar, M., Bragadin, L. M., Zanier, F., Antonello, R. M., &Cazzato, G. (2000). Olfactory dysfunction and extent of white matter abnormalities in multiple sclerosis: A clinical and MR study. Multiple Sclerosis, 6, 386-390.